In this issue:
Effectiveness of SGLT-2 inhibitorsvs. sulfonylureas in type 2 diabetes
Add-on weekly tirzepatide vs. daily insulin degludec in type 2 diabetes
Diabetes trends in US adults/ youths, and gestational diabetes
Impact of sotagliflozin on hospitalisations in type 2 diabetes with worsening HF
Once-weekly semaglutide 2.0mg vs. 1.0mg in type 2 diabetes
Long-term trends in CV disease incidence in type 1 diabetes
Dapagliflozin: impact on albuminuria, and efficacy/safety according to glycaemic status
Please login below to download this issue (PDF)